PathoAI

PathoAI, a company at the forefront of intelligent pathology and examination through artificial intelligence (AI), has reportedly raised tens of millions of renminbi in an angel financing round. The funding was led by Hangzhou Taikun Equity Investment Fund Partnership, with participation from Deshi Capital. PathoAI’s Focus on AI Products and…